GlassScriptPhysician profile
Arooj S Kayani
NPI 1851653521
$8,344.42
in general payments reported to CMS, 2019-2025
10 companies · $2,458 in 2025
The $2,458 reported for 2025 was more than what 95% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $31.81 · 2022: $2,238 · 2023: $3,270 · 2024: $348 · 2025: $2,458.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,160 · Travel and Lodging: $1,796 · Food and Beverage: $1,119.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,159.75 |
| Travel and Lodging | $1,796.03 |
| Food and Beverage | $1,119.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,539.29 | 2022-2025 | Da Vinci Surgical System |
| Astrazeneca Pharmaceuticals LP | $212.50 | 2024 | Airsupra, Tagrisso |
| Sanofi-Aventis U.S. LLC | $159.75 | 2024-2025 | |
| Electromed, INC. | $122.08 | 2022-2025 | Smartvest |
| Regeneron Healthcare Solutions, INC. | $121.59 | 2023 | Dupixent |
| Glaxosmithkline, LLC. | $99.47 | 2021-2025 | Trelegy Ellipta |
| Insmed, INC. | $30.25 | 2025 | Arikayce |
| Actelion Pharmaceuticals US, INC. | $23.80 | 2025 | Uptravi, Opsumit |
| Genzyme Corporation | $21.22 | 2025 | |
| Baxter Healthcare | $14.47 | 2023 | Hillrom - Vest System Model 105 Home Care |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arooj Kayani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.